Secondary outcomes analyzed were preterm births, serum/plasma hemoglobin (g/L), infant mortality, serum/plasma transferrin receptor (mg/L), neonatal mortality and serum/plasma ferritin (ug/L) (2) For Iron vs. Placebo, the primary outcomes were low birth weight, maternal anaemia and perinatal mortality. This evidence concerns the gene TFRC and anemia.